AstraZeneca, Oxford aim to produce Omicron-targeted vaccine

Published by

(Reuters) -AstraZeneca Plc said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant-specific vaccine. “Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed and will be informed by emerging data,” a spokesperson for the company said in a statement. Oxford did not immediately respond to a request for comment outside business hours. The Financial Times first reported the news, citing Sandy Douglas, a res…

Read More

Leave a Reply